These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3816231)

  • 1. Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women.
    Swahn ML; Wang G; Aedo AR; Cekan SZ; Bygdeman M
    Contraception; 1986 Nov; 34(5):469-81. PubMed ID: 3816231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of the antiprogestin RU 486 and its metabolites in human blood and follicular fluid following oral administration of a single dose.
    Cekan S; Aedo AR; Segerstéen E; Van Look P; Messinis I; Templeton A
    Hum Reprod; 1989 Feb; 4(2):131-5. PubMed ID: 2918065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy termination with a high and medium dosage regimen of RU 486.
    Shoupe D; Mishell DR; Brenner PF; Spitz IM
    Contraception; 1986 May; 33(5):455-61. PubMed ID: 3757511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
    N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
    Gaillard RC; Herrmann W
    Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of very early pregnancy by RU 486--an antiprogestational compound.
    Kovacs L; Sas M; Resch BA; Ugocsai G; Swahn ML; Bygdeman M; Rowe PJ
    Contraception; 1984 May; 29(5):399-410. PubMed ID: 6744860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist.
    Maria B; Stampf F; Goepp A; Ulmann A
    Eur J Obstet Gynecol Reprod Biol; 1988 Jul; 28(3):249-55. PubMed ID: 3208966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.
    Gaillard RC; Riondel A; Muller AF; Herrmann W; Baulieu EE
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3879-82. PubMed ID: 6328529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue.
    Maria B; Stampf F; Goepp A; Dubois C
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):35-40. PubMed ID: 2376278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
    Rodger MW; Baird DT
    Contraception; 1989 Oct; 40(4):439-47. PubMed ID: 2582769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the antiprogesterone RU 486 in women during multiple dose administration.
    Heikinheimo O
    J Steroid Biochem; 1989 Jan; 32(1A):21-5. PubMed ID: 2913396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML; Bygdeman M
    Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability.
    Grimes DA; Mishell DR; David HP
    Contraception; 1992 Jul; 46(1):1-10. PubMed ID: 1424618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
    Bygdeman M; Swahn ML
    Contraception; 1985 Jul; 32(1):45-51. PubMed ID: 4053605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
    Olajide F; Howell RJ; Wass JA; Holly JM; Bohn H; Grudzinskas JG; Chapman MG; Chard T
    Hum Reprod; 1989 Apr; 4(3):337-40. PubMed ID: 2715311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy.
    Hill NC; Selinger M; Ferguson J; MacKenzie IZ
    Hum Reprod; 1991 Mar; 6(3):458-62. PubMed ID: 1955558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.